Skip to main content

Research Repository

Advanced Search

Discovery of novel antitumor nitric oxide-donating β-elemene hybrids through inhibiting the PI3K/Akt pathway

Chen, Jichao; Wang, Tianyu; Xu, Shengtao; Zhang, Pengfei; Lin, Aijun; Wu, Liang; Yao, Hequan; Xie, Weijia; Zhu, Zheying; Xu, Jinyi

Discovery of novel antitumor nitric oxide-donating  β-elemene hybrids through inhibiting the PI3K/Akt pathway Thumbnail


Authors

Jichao Chen

Tianyu Wang

Shengtao Xu

Pengfei Zhang

Aijun Lin

Liang Wu

Hequan Yao

Weijia Xie

ZHEYING ZHU Zheying.Zhu@nottingham.ac.uk
Associate Professor in International Pharmacy and Traditional Medicines

Jinyi Xu



Abstract

A series of novel furoxan-based NO-donating b-elemene hybrids were designed and synthesized to improve the anticancer efficacy of natural b-elemene. The bioassay results indicated that all of the target compounds exhibited significantly improved antiproliferative activities against three cancer cell lines (SGC-7901, HeLa and U87) compared to parent compound b-elemene. Interestingly, these compounds displayed excellent sensitivity to U87 cells with IC50 values ranging from 173 to 2 nM. Moreover, most compounds produced high levels of NO in vitro, and the antitumor activity of 11a in U87 cells was markedly attenuated by an NO scavenger (hemoglobin or carboxy-PTIO). Further mechanism studies revealed that 11a caused the G2 phase arrest of the cell cycle and induced apoptosis of U87 cells by preventing the activation of the PI3K/Akt pathway. Moreover, 11a significantly suppressed the tumor growth in H22 liver cancer xenograft mouse model with a tumor inhibitory ratio (TIR) of 64.8%, which
was superior to that of b-elemene (TIR, 49.6%) at the same dose of 60 mg/kg. Together, the remarkable biological profiles of these novel NO-donating b-elemene derivatives may make them promising candidates for the intervention of human cancers.

Citation

Chen, J., Wang, T., Xu, S., Zhang, P., Lin, A., Wu, L., …Xu, J. (2017). Discovery of novel antitumor nitric oxide-donating β-elemene hybrids through inhibiting the PI3K/Akt pathway. European Journal of Medicinal Chemistry, 135, https://doi.org/10.1016/j.ejmech.2017.04.045

Journal Article Type Article
Acceptance Date Apr 19, 2017
Online Publication Date Apr 20, 2017
Publication Date Jul 28, 2017
Deposit Date May 17, 2017
Publicly Available Date May 17, 2017
Journal European Journal of Medicinal Chemistry
Print ISSN 0223-5234
Electronic ISSN 1768-3254
Publisher Elsevier
Peer Reviewed Peer Reviewed
Volume 135
DOI https://doi.org/10.1016/j.ejmech.2017.04.045
Keywords β-Elemene; Furoxan; Antitumor activity; Apoptosis; PI3K/Akt pathway
Public URL https://nottingham-repository.worktribe.com/output/874737
Publisher URL http://www.sciencedirect.com/science/article/pii/S0223523417303112
Contract Date May 17, 2017

Files





You might also like



Downloadable Citations